NO991198L - FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel - Google Patents

FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel

Info

Publication number
NO991198L
NO991198L NO991198A NO991198A NO991198L NO 991198 L NO991198 L NO 991198L NO 991198 A NO991198 A NO 991198A NO 991198 A NO991198 A NO 991198A NO 991198 L NO991198 L NO 991198L
Authority
NO
Norway
Prior art keywords
plasma
plasma protein
drug
citrate
preparation
Prior art date
Application number
NO991198A
Other languages
English (en)
Norwegian (no)
Other versions
NO991198D0 (no
Inventor
Wolfgang Teschner
Yendra Linnau
Sonja Svatos
Herwig Igel
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3517640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO991198(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO991198D0 publication Critical patent/NO991198D0/no
Publication of NO991198L publication Critical patent/NO991198L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO991198A 1996-09-16 1999-03-11 FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel NO991198L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0163396A AT403989B (de) 1996-09-16 1996-09-16 Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
PCT/AT1997/000197 WO1998012225A2 (de) 1996-09-16 1997-09-10 Verfarhen zur herstellung eines plasmaprotein-hältigen arzneimittels

Publications (2)

Publication Number Publication Date
NO991198D0 NO991198D0 (no) 1999-03-11
NO991198L true NO991198L (no) 1999-05-14

Family

ID=3517640

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991198A NO991198L (no) 1996-09-16 1999-03-11 FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel

Country Status (24)

Country Link
US (3) US20020034809A1 (cs)
EP (1) EP0927195B1 (cs)
JP (1) JP2001500867A (cs)
KR (1) KR20000036002A (cs)
CN (1) CN1230967A (cs)
AR (1) AR009582A1 (cs)
AT (2) AT403989B (cs)
AU (1) AU732519B2 (cs)
BR (1) BR9712044A (cs)
CA (1) CA2265936C (cs)
CZ (1) CZ91199A3 (cs)
DE (1) DE59710700D1 (cs)
DK (1) DK0927195T3 (cs)
ES (1) ES2206701T3 (cs)
HU (1) HUP0002265A3 (cs)
ID (1) ID21224A (cs)
IL (1) IL128770A0 (cs)
IN (1) IN187314B (cs)
MX (1) MXPA99002144A (cs)
NO (1) NO991198L (cs)
PL (1) PL332159A1 (cs)
PT (1) PT927195E (cs)
SK (1) SK32899A3 (cs)
WO (1) WO1998012225A2 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT408946B (de) * 1999-02-18 2002-04-25 Immuno Ag Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
PL370652A1 (en) 2001-12-21 2005-05-30 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
DE602004025100D1 (de) * 2003-05-23 2010-03-04 Novo Nordisk Healthcare Ag Stabilisierung von proteinen in lösung
KR101293503B1 (ko) 2003-08-14 2013-08-07 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 vii 폴리펩티드의 액상 수성 약학적 조성물
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
US8497124B2 (en) 2011-12-05 2013-07-30 Factor Bioscience Inc. Methods and products for reprogramming cells to a less differentiated state
KR20240039237A (ko) 2011-12-05 2024-03-26 팩터 바이오사이언스 인크. 세포를 형질감염시키는 방법들 및 생성물들
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
JP7097433B2 (ja) 2017-08-17 2022-07-07 ジャスト-エヴォテック バイオロジックス、インコーポレイテッド 宿主細胞ガレクチンおよび他の夾雑物からグリコシル化タンパク質を精製する方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE384134C (de) * 1921-05-07 1923-10-25 Chemisch Pharmazeutische Werke Verfahren zur Herstellung eines Kamillenextraktes
DE2331854A1 (de) * 1973-06-22 1975-01-16 Greither Salus Haus Dr Otto Verfahren zur herstellung standardisierter arzneimittel aus kamillenblueten
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
SE500110C2 (sv) * 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
US5744586A (en) * 1996-06-26 1998-04-28 Alpha Therapeutic Corporation Manufacturing process for the production of purified transferrin
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies

Also Published As

Publication number Publication date
WO1998012225A2 (de) 1998-03-26
CA2265936C (en) 2008-04-22
ATA163396A (de) 1997-12-15
HUP0002265A3 (en) 2003-01-28
NO991198D0 (no) 1999-03-11
KR20000036002A (ko) 2000-06-26
CN1230967A (zh) 1999-10-06
EP0927195B1 (de) 2003-09-03
IN187314B (cs) 2002-03-23
US20020034809A1 (en) 2002-03-21
AU732519B2 (en) 2001-04-26
EP0927195A2 (de) 1999-07-07
ATE248857T1 (de) 2003-09-15
WO1998012225A3 (de) 1998-04-23
PL332159A1 (en) 1999-08-30
CZ91199A3 (cs) 1999-06-16
ID21224A (id) 1999-05-06
AT403989B (de) 1998-07-27
IL128770A0 (en) 2000-01-31
AU4289997A (en) 1998-04-14
BR9712044A (pt) 1999-08-24
DK0927195T3 (da) 2003-11-24
CA2265936A1 (en) 1998-03-26
ES2206701T3 (es) 2004-05-16
PT927195E (pt) 2004-01-30
JP2001500867A (ja) 2001-01-23
AR009582A1 (es) 2000-04-26
SK32899A3 (en) 1999-08-06
US8709492B2 (en) 2014-04-29
US20140234292A1 (en) 2014-08-21
HUP0002265A2 (hu) 2000-11-28
DE59710700D1 (de) 2003-10-09
US20050249815A1 (en) 2005-11-10
MXPA99002144A (es) 2005-04-28

Similar Documents

Publication Publication Date Title
NO991198L (no) FremgangsmÕte ved fremstilling av et plasmaproteinholdig legemiddel
Rhoads et al. Purification and properties of collagen proline hydroxylase from newborn rat skin
Wahlestedt et al. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat
NO20024082D0 (no) Fremgangsmåte for fremstilling av peptider ved anvendelse av in vitro transkripsjons-/translasjonssystem
Jennett et al. Preferential covalent binding of acetaldehyde to the α‐chain of purified rat liver tubulin
JP2000507811A (ja) マクロファージ遊走阻止因子の阻害剤の同定のためのスクリーニング方法
DE602005004014D1 (de) Verfahren zur solubilisierung von peptid-mischungen
Vincent et al. Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients
ATE255646T1 (de) Verfahren zur wärmebehandlung von strukturgussteilen aus einer dafür zu verwendenden aluminiumlegierung
ATE358139T1 (de) Verfahren zur herstelllung von gonadotropin- zusammensetzungen
Liao et al. Prostate alpha-protein. Complete amino acid sequence of the component that inhibits nuclear retention of the androgen-receptor complex.
EP1111533A3 (en) Logistic regression trees for drug analysis
ATE273944T1 (de) Verfahren zur entfernung von schwermetallen
Decock-Le Reverend et al. Some aspects of the thioether donation in aminoacids and peptides complexes
RU95103323A (ru) Способ обогащения по благородным металлам свинцового сплава (веркблея)
Laxton et al. The antioxidant enzyme quinone reductase is up-regulated in vivo following cerebral ischemia
Imai et al. A possible function of thiols, including glutathione, as cofactors in the conversion of thyroxine to 3, 3', 5-triiodothyronine in rat liver microsomes
RU2077779C1 (ru) Способ безотходной гидрометаллургической переработки стружковых отходов сплава алюминий-медь-олово
DK0946563T3 (da) Fremgangsmåde til udvinding af hæmatitjern fra slagteblod
DE60042170D1 (de) Verfahren zur oxidaton von xylen-derivaten
Schooley et al. The destruction by neuraminidase of the biological activity of erythropoietin when complexed with antierythropoietin
Gubenko et al. Nature of Microfractures Close to Sulphide Inclusions in Steel During Deformation After Laser Treatment
EA200000444A1 (ru) Способ удаления богатых азотом включений в титане и его сплавах
Meshalkin et al. Dual-photon excitation of albumin
馬許蘭 et al. Kinetics and Mechanism of Oxidation of Leucine and Phenylalanine by N-Bromosuccniimide in Acidic Media

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application